MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
Abstract Background Diabetes is a leading cause of mortality and morbidity across the world. Over 50% of deaths among diabetic patients are caused by cardiovascular diseases. Cardiac diastolic dysfunction is one of the key early signs of diabetic cardiomyopathy, which often occurs before systolic dy...
Main Authors: | Beibei Dai, Huaping Li, Jiahui Fan, Yanru Zhao, Zhongwei Yin, Xiang Nie, Dao Wen Wang, Chen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-018-0767-z |
Similar Items
-
Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy
by: Massimo Chiariello, et al.
Published: (2006-09-01) -
Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
by: Kathrin Cordts, et al.
Published: (2019-07-01) -
Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis
by: Salem Elsayed Deraz, et al.
Published: (2023-06-01) -
Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy
by: Yoo-Ri Chung, et al.
Published: (2017-07-01) -
DIASTOLIC DYSFUNCTION IN DIABETES MELLITUS
by: Nikhil M Dikshit, et al.
Published: (2013-09-01)